Is REVBU or XYLD a better dividend investment in 2026?

REVBU currently yields 690.37% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: REVBU offers higher current income.

What is the dividend yield difference between REVBU and XYLD?

REVBU has a forward dividend yield of 690.37% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 679.39 percentage points.

Home › Compare › REVBU vs XYLD

REVBU vs XYLD: Dividend Comparison 2026

REVBU yields 690.37% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 REVBU wins by $810427.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

REVBU

● Live price

690.37%

Share price

$0.29

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$810427.07M

Annual income

$630,711,075,666.81

Full REVBU calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — REVBU vs XYLD

📍 REVBU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	REVBU	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, REVBU + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

REVBU pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REVBU

Annual income on $10K today (after 15% tax)

$58,681.39/yr

After 10yr DRIP, annual income (after tax)

$536,104,414,316.79/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, REVBU beats the other by $536,104,411,580.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REVBU + XYLD for your $10,000?

REVBU: 50%XYLD: 50%

100% XYLD50/50100% REVBU

Portfolio after 10yr

$405213.55M

Annual income

$315,355,539,442.92/yr

Blended yield

77.82%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on REVBU right now

REVBU

Analyst Ratings

Buy

Consensus: Buy

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REVBU buys

XYLD buys

No recent congressional trades found for REVBU or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricREVBUXYLD

Forward yield	690.37% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$810427.07M ✓	$25.3K
Annual income after 10y	$630,711,075,666.81 ✓	$3,219.02
Total dividends collected	$795837.92M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: REVBU vs XYLD ($10,000, DRIP)

Year	REVBU Portfolio	REVBU Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$79,737	$69,036.93	$10,818	$1,098.39	+$68.9K → REVBU
2	$599,785	$514,466.69	$11,738	$1,222.51	+$588.0K → REVBU
3	$4,258,447	$3,616,676.77	$12,774	$1,364.64	+$4.25M → REVBU
4	$28,554,890	$23,998,351.37	$13,944	$1,527.86	+$28.54M → REVBU
5	$180,946,473	$150,392,741.11	$15,270	$1,715.87	+$180.93M → REVBU
6	$1,084,274,338	$890,661,611.68	$16,775	$1,933.09	+$1084.26M → REVBU
7	$6,148,076,706	$4,987,903,165.00	$18,490	$2,184.87	+$6148.06M → REVBU
8	$33,010,704,292	$26,432,262,216.06	$20,450	$2,477.63	+$33010.68M → REVBU
9	$167,958,874,690	$132,637,421,097.63	$22,697	$2,819.19	+$167958.85M → REVBU
10	$810,427,071,585	$630,711,075,666.81	$25,280	$3,219.02	+$810427.05M → REVBU

REVBU vs XYLD: Complete Analysis 2026

REVBU — Stock

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.

Full REVBU Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this REVBU vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REVBU vs SCHD REVBU vs JEPI REVBU vs O REVBU vs KO REVBU vs MAIN REVBU vs QYLD REVBU vs JEPQ REVBU vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.